ZTS Zoetis Inc. NYSE · United States

Zoetis (ZTS) news

Zoetis Inc. is a public biotech or pharmaceutical company listed on NYSE under the ticker ZTS, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Zoetis news

We have not published a story on Zoetis yet. When there is news, it will appear here.

Zoetis annual financials

Line	FY2025	FY2024
Revenue	$9.47 billion	$9.26 billion
Research and development	$698.0 million	$686.0 million
Net income (loss)	$2.67 billion	$2.49 billion
Cash from operations	$2.90 billion	$2.95 billion
Cash and equivalents	$2.45 billion	$1.99 billion
Short-term investments	$0

Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $1.48 billion, plus short-term investments of $200.0 million, $1.68 billion in all.

Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.

Questions about Zoetis

What is the ticker symbol of Zoetis?

Zoetis Inc. trades under the ticker ZTS on NYSE.

Where is Zoetis listed?

Zoetis Inc. is listed on NYSE.

Which country or territory is Zoetis listed under?

Our directory records Zoetis Inc. under United States.

Does aibio.space cover Zoetis?

aibio.space lists Zoetis Inc. among 2,820 public biotech companies and publishes its news here as stories appear.

What was Zoetis's revenue last year?

$9.47 billion for the fiscal year ended Dec 31, 2025, as reported to the SEC.

Is Zoetis profitable?

Zoetis Inc. reported net income of $2.67 billion for the fiscal year ended Dec 31, 2025, and generated $2.90 billion of cash from operations, per its annual report to the SEC.

How much does Zoetis spend on research and development?

$698.0 million in the fiscal year ended Dec 31, 2025, per its annual report.

How much cash does Zoetis have?

$1.68 billion in cash and short-term investments at Jun 30, 2026, per its 10-Q.

Investor discussion: Zoetis

Members talk about Zoetis (ZTS). Reader posts, not aibio.space reporting, and not investment advice.

Rules

Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at Zoetis, newest first. Each line links the filing it comes from.

Aug 6, 2026Legal
Disclosed a shareholder lawsuit, subpoena or other legal matter. SEC Form 10-Q. Source

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open NYSE:ZTS on TradingView.

Listing details

Company: Zoetis Inc.
Ticker: ZTS
Listing: NYSE
Country or territory: United States

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction